LEOS INVEST AS • 989218867 • Drammen • Wholesale trade, except of motor vehicles and motorcycles

This website uses cookies to enhance the user experience.

Goods and trade

/ Purchase and sale

/ 46.460 Wholesale of pharmaceutical goods

LEOS INVEST AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO: BH
Bjørn Helmer Johnsen1950
Chairman of the board: BH
Bjørn Helmer Johnsen1950
Years since formation: 19 years; since Mar 22, 2006
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 2,400; 1 share class
Total number of shareholders: 1; person
Belongs to group of

Financials

Annual total result 2024: 1,876,573; NOK
Total equity 2024: 69,025,740; NOK

Last update: May 31, 2025

Management

Management / administration

Name	Role	Shares
BH Bjørn Helmer Johnsen 1950	Managing Director/CEO	100 % directly

Board

Name	Role	Shares
BH Bjørn Helmer Johnsen 1950	Chairman	100 % directly
JM Jorunn Mathiesen Knutsen 1966	Alternate Member	-

Others

Name	Role	Shares
R REVISORKOLLEGIET AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
BH Bjørn Helmer Johnsen 1950	Managing Director/CEO, Chairman	100 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
BH Bjørn Helmer Johnsen 1950	Ordinary shares	2,400	100 %

Shares owned by the LEOS INVEST AS

Name	Share class	Total number of shares	Share
S SCAN-MED AS NORWAY	Ordinary shares	12,000	100 %
A ATTIVO EIENDOMSINVEST AS	NO0010450299	2,000	0.7 %
G GAMLE BORGENVEI 20 INVEST AS	NO0010625023	10,000	0.67 %

Last update: Jun 2, 2025

Group structure

LEOS INVEST AS
Total operating income 2024: NOK 0
Operating profit 2024: NOK -318,942
Employees: 0

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Annual Total Result	1,876,573	1,359,968	-1,533,011	6,953,062
Total assets	82,925,403	67,227,420	65,804,797	77,595,621
Total liabilities	13,899,663	78,253	15,598	10,273,410
Total equity	69,025,740	67,149,167	65,789,199	67,322,211

P&L

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Total operating costs	318,942	291,654	262,871	261,106
Operating result	-318,942	-291,654	-262,871	-261,106
Financial income/costs	2,315,980	1,729,875	-1,251,553	7,217,308
Profit before tax	1,997,038	1,438,221	-1,514,424	6,956,203
Total tax & extraordinary income/cost	120,465	78,253	18,587	3,141
Annual Total Result	1,876,573	1,359,968	-1,533,011	6,953,062

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	60,979,918	46,472,902	32,028,994	32,031,983
Total current assets	21,945,485	20,754,518	33,775,803	45,563,638
Total assets	82,925,403	67,227,420	65,804,797	77,595,621
Short term debt	13,899,663	78,253	15,598	10,273,410
Long term debt	0	0	0	0
Total liabilities	13,899,663	78,253	15,598	10,273,410
Contributed capital	26,184,021	26,184,021	26,184,021	26,184,021
Retained earnings	42,841,719	40,965,146	39,605,178	41,138,190
Total equity	69,025,740	67,149,167	65,789,199	67,322,211
Total equity and liabilities	82,925,403	67,227,420	65,804,797	77,595,621

Classification

Category

Goods and trade

/ Purchase and sale

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

G

Main industrial area

Wholesale and retail trade; repair of motor vehicles and motorcycles

46

Activity

Wholesale trade, except of motor vehicles and motorcycles

46.4

Main industrial group

Wholesale of household goods

46.46

Industrial group

Wholesale of pharmaceutical goods

46.460

Industrial group

Wholesale of pharmaceutical goods